Edit protocol

Name

Category

Slug

URL fragment. Auto-generated from name if blank.

Content (Markdown)

# TAURINE

## Product Information

**Drug:** Taurine (amino sulfonic acid)

**Concentration:** 50 mg/mL

**Vial size:** 10 mL (total = 500 mg taurine)

**Route:** IV infusion (diluted; not for undiluted IV push)

## Dosage Ranges

- **Standard dose:** 250–500 mg IV (≈5–10 mL of 50 mg/mL solution)
- **High dose:** up to 1000 mg IV (20 mL, if concentrated stock available or compounded)
- **Dilution:** Add to 250–500 mL carrier fluid (0.9% NaCl, Hartmann's, or CSL)
- **Infusion time:** 30–60 minutes
- **Frequency:** weekly to fortnightly

## Clinical / Wellness Benefits

- Cardiac support: regulates calcium flow, helps stabilise heart rhythm
- Neurological health: calming effect on the nervous system; GABA-like action
- Antioxidant: reduces oxidative stress, supports mitochondrial health
- Exercise & recovery: reduces muscle fatigue, supports hydration/electrolyte balance
- Metabolic support: may improve insulin sensitivity and lipid metabolism
- Synergy: often combined with magnesium, B-complex, and glutathione

## Safety & Precautions

- Well tolerated when infused slowly in diluted form
- Avoid rapid push → may cause hypotension, dizziness, flushing
- Use caution in renal impairment (amino acid clearance may be reduced)
- Baseline renal & hepatic function recommended if repeated use
- No known major drug interactions at wellness doses

## Australian Injectable Drugs Handbook

Taurine

No data on Taurine on AIDH

Cancel